Traditional anti-cancer treatments are inefficient against glioblastoma, which remains one of
the deadliest and most aggressive cancers. Nano-drugs could help to improve this situation …

Simple Summary As one of the most lethal human cancers, glioblastoma treatment is a real
challenge because of several resistance mechanisms, including limited drug entry into the …

Context: Glioblastoma multiforme (GBM) is by far the most common and aggressive form of
glial tumor. It is characterized by a highly proliferative population of cells that invade …

Glioblastoma (GBM) is one of the most aggressive cancers of the brain. Despite extensive
research over the last several decades, the survival rates for GBM have not improved and …

Even though substantial advances in understanding glioma pathogenesis have prompted a
more rational design of potential therapeutic strategies, glioblastoma multiforme remains an …

Glioblastoma multiforme (GBM), a grade IV astrocytoma as defined by the World Health
Organization (WHO) criteria, is the most common primary central nervous system tumor in …

Glioblastoma (GBM) is one of the most aggressive and deadliest central nervous system
tumors, and the current standard treatment is surgery followed by radiotherapy with …

Advances in technology of the past decades led to development of new nanometer scale
diagnosis and treatment approaches in cancer medicine leading to establishment of …

Treatment of glioblastoma multiforme (GBM), a primary malignant tumor of the brain, is one
of the most challenging problems as no currently available treatment is curative. Surgery …

High-grade gliomas are still characterized by a poor prognosis, despite recent advances in
surgical treatment. Chemotherapy is currently practiced after surgery, but its efficacy is …